On June 15, 2024, MBA Pharma attended the 9th Conference of the Ho Chi Minh City Wound Care Association, a prestigious forum gathering leading experts in wound care. At the event, MBA Pharma introduced its Hyalo4 product line, featuring 200kDa hyaluronic acid, a significant advancement in wound treatment.
Hyalo4 drew attention for its ability to create an ideal moist environment for tissue regeneration, thus accelerating the wound healing process effectively and efficiently. The latest research on the effectiveness of 200kDa hyaluronic acid in this field was presented and thoroughly discussed at the conference, receiving positive feedback from professionals.
A Scientific Forum with Many Beneficial Activities
In addition to expert presentations, the conference also hosted various engaging activities such as themed workshops and exhibitions showcasing advanced medical products. This provided an excellent opportunity for doctors, specialists, and researchers to exchange knowledge and experiences, working together to discover new solutions in wound care and treatment.
MBA Pharma hopes that its participation and advanced products will contribute to significant progress in improving wound care quality for patients.
